financetom
Business
financetom
/
Business
/
McDonald's appoints new licensee for north and east India operations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
McDonald's appoints new licensee for north and east India operations
Feb 3, 2020 12:46 AM

Nine months after buying out Vikram Bakshi's stake in Connought Plaza Restaurants Limited (CPRL), McDonald's has finally selected its developmental licensee to run the north and east India operations.

Share Market Live

NSE

Sanjeev Agarwal from the diversified MM Agarwal Group has bagged McDonald's mandate.

"Mr Agrawal has a strong understanding and passion for the McDonald’s brand, insights into the local market, and a proven track record of driving quality and innovation in the food and beverage and hospitality industries. He is the right strategic partner for McDonald’s to grow our brand presence in north and east India," said Barry Sum, director, corporate relations, McDonald's Asia.

The MM Agarwal group also runs Moon Beverages, Coca Cola's largest franchisee bottler.

Robert Hunghanfoo will continue to head CPRL.

McDonald’s and Agarwal will work together to create "exciting experiences for customers in N&E India by modernizing restaurants, enhancing digital consumer engagement, and offering more personalized service and menu items tailored to their local flavor," the company said.

McDonald's refused to disclose the terms of the deal or details of the transaction.

Over the past year several groups like the RP Sanjiv Goenka Group and Bird Group had expressed interest to run the McDonald's 165 restaurants in north and east India.

First Published:Feb 3, 2020 9:46 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AI-Powered Grid? Itron And NVIDIA Join Forces To Transform Utilities With Smarter, Faster Solutions
AI-Powered Grid? Itron And NVIDIA Join Forces To Transform Utilities With Smarter, Faster Solutions
Mar 20, 2025
On Wednesday, Itron, Inc. ( ITRI ) announced a new collaboration with NVIDIA Corporation ( NVDA ) to accelerate the adoption of AI-powered solutions at the grid edge, helping utilities and communities tackle some of the industry’s challenges. Itron ( ITRI ) shares are trading relatively flat in the premarket session on Thursday. This partnership integrates Itron’s advanced Grid Edge...
Microsoft Well Positioned to Benefit From AI Growth, Despite Market Jitters,  Wedbush Says
Microsoft Well Positioned to Benefit From AI Growth, Despite Market Jitters, Wedbush Says
Mar 20, 2025
08:18 AM EDT, 03/20/2025 (MT Newswires) -- Microsoft ( MSFT ) shares have been under pressure due to concerns over AI-driven growth and competition, but recent checks with customers and partners reveal an acceleration in deal flow, boosting confidence in Azure's growth, Wedbush said in a note on Thursday. AI annual recurring revenue continues to track ahead of expectations, reaching...
Academy Sports and Outdoors' Fiscal Q4 Adjusted Earnings, Net Sales Fall; Issues Fiscal 2025 Guidance
Academy Sports and Outdoors' Fiscal Q4 Adjusted Earnings, Net Sales Fall; Issues Fiscal 2025 Guidance
Mar 20, 2025
08:19 AM EDT, 03/20/2025 (MT Newswires) -- Academy Sports and Outdoors ( ASO ) reported fiscal Q4 adjusted earnings Thursday of $1.96 per diluted share, down from $2.21 per share a year earlier. Analysts polled by FactSet expected $1.83. Net Sales for the quarter ended Feb. 1 was $1.68 billion, down from $1.79 billion a year earlier. Analysts surveyed by...
Creative Medical Receives FDA Approval to Expand Dosing in Back Pain Trial
Creative Medical Receives FDA Approval to Expand Dosing in Back Pain Trial
Mar 20, 2025
08:16 AM EDT, 03/20/2025 (MT Newswires) -- Creative Medical Technology ( CELZ ) said Thursday the US Food and Drug Administration has allowed an increased dosing plan in its ongoing phase 1/2 trial of its cell therapy targeting chronic lower back pain caused by degenerative disc disease. The decision follows interim blinded results showing significant pain reduction and mobility improvements...
Copyright 2023-2026 - www.financetom.com All Rights Reserved